Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

University Hospital Würzburg at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

University Hospital Würzburg brings 9 presentations to ASH 2026 in New Orleans. Its research centres on multiple myeloma, especially GPRC5D and CD38 therapies. Work covers talquetamab in real-world use, ataxia after GPRC5D treatment and a 3D mini-bone model of myeloma.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
Academic hospital of the University of Würzburg in Bavaria, Germany.
Symposium
Fri Dec 11
3:00pm–6:00pm
The Rising Tide of Bispecifics in NHL: Off-the-Shelf Opportunities From Later-Line to Frontline Care
Bispecific antibodies moving from late to early treatment of non-Hodgkin lymphoma, with outpatient step-up dosing and control of immune side effects.
Symposium hosted by PeerView Institute for Medical Education
Lymphoma · New drugs

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University Hospital Würzburg

Tell us what you sell and we’ll find the people at University Hospital Würzburg most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction